Autolus Therapeutics Plc (AUTL)
1.615
-0.10
(-6.10%)
USD |
NASDAQ |
Oct 16, 13:09
Autolus Therapeutics SG&A Expense (TTM) : 152.92M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 152.92M |
| March 31, 2026 | 142.30M |
| December 31, 2025 | 131.95M |
| September 30, 2025 | 129.57M |
| June 30, 2025 | 120.85M |
| March 31, 2025 | 112.13M |
| December 31, 2024 | 100.77M |
| September 30, 2024 | 83.14M |
| June 30, 2024 | 66.42M |
| March 31, 2024 | 55.64M |
| December 31, 2023 | 46.74M |
| September 30, 2023 | 38.43M |
| June 30, 2023 | 36.05M |
| March 31, 2023 | 33.20M |
| December 31, 2022 | 31.90M |
| Date | Value |
|---|---|
| September 30, 2022 | 32.08M |
| June 30, 2022 | 32.15M |
| March 31, 2022 | 31.11M |
| December 31, 2021 | 31.86M |
| September 30, 2021 | 33.28M |
| June 30, 2021 | 34.82M |
| March 31, 2021 | 36.10M |
| December 31, 2020 | 34.97M |
| September 30, 2020 | 35.89M |
| June 30, 2020 | 34.65M |
| March 31, 2020 | 37.51M |
| December 31, 2019 | 39.45M |
| September 30, 2019 | 29.53M |
| June 30, 2019 | 20.93M |
| March 31, 2019 | 9.556M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Bicycle Therapeutics Plc | 71.10M |
| Biodexa Pharmaceuticals Plc | 5.629M |
| argenx SE | 1.537B |
| Mereo BioPharma Group Plc | 19.44M |
| Evaxion AS | 4.527M |